Stimulation of serotonin (5-HT)(1A) receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats

Behavioural Pharmacology

Volumn 8, Issue 8, 1997, Pages 699-706

  Przegalinski E ^a   Filip, M ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT(1A) receptors; Amphetamine; Cocaine; Drug discrimination; Locomotor activity; Rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AMPHETAMINE; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMPHETAMINE; ANIMALS; COCAINE; DISCRIMINATION (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; STIMULATION, CHEMICAL;

EID: 0031445970     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199712000-00004     Document Type: Article

References (55)

1. 1A agonist 8-OH-DPAT in the rat. Pharmacology and Toxicology, 64, 3-5.
2. Alheid GF and Heimer L (1988) New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience, 27, 1-39.
3. Ali I and Kelly ME (1996) 8-OH-DPAT enhances the expression of cocaine-induced place preference in the mouse. British Journal of Pharmacology, Suppl. 119, 207P.
4. Arnt J (1995) Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine. European Journal of Pharmacology, 283, 55-62.
5. Benloucif S and Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. European Journal of Pharmacology, 200, 1-8.
6. Breese GR, Cooper BR and Mueller RA (1974) Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine. British Journal of Pharmacology, 52, 307-314.
7. 2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology, 105, 335-339.
8. 2C receptors. Journal of Pharmacology and Experimental Therapeutics, 274, 1414-1424.
9. 2 mediation of the discriminative stimulus properties of D-amphetamine and cocaine. Psychopharmacology, 103, 50-55.
10. 1 receptors in the nucleus accumbens. Psychopharmacology, 115, 110-114.
11. Carroll ME, Lac ST, Asencio M and Kragh R (1990a) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacology, Biochemistry and Behavior, 35, 237-244.
12. Carroll ME, Lac ST, Asencio M and Kragh R (1990b) Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology, 100, 293-300.
13. Carter CJ and Pycock CJ (1978) Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Life Sciences, 23, 953-960.
14. Chen N-H and Reith MEA (1995) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propyl-amino)tetralin. Journal of Neurochemistry, 64, 1585-1597.
15. Costall B, Fortune DH, Hui S-CG and Naylor RJ (1980) Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interation at presynaptic receptors? European Journal of Pharmacology, 63, 347-358.
16. Cunningham KA and Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology, 104, 177-180.
17. 3 compounds in a drug discrimination model. Pharmacology, Biochemistry and Behavior, 54, 533-540.
18. Elliott PJ, Walsh DM, Close SP, Higgins GA and Hayes AG (1990) Behavioural effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology, 29, 949-956.
19. Filip M and Przegaliñski E (1997) The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats. Polish Journal of Pharmacology, 49, 21-30.
20. Filip M and Przegalinski E (1997b) The role of the nitric oxide (NO) pathway in the discriminative stimulus effects of amphetamine and cocaine in rats. Pharmacology, Biochemisty and Behavior, in press.
21. 1A receptors. European Journal of Pharmacology, 237, 283-291.
22. Gervais J and Rouillard C (1993) Electrophysiological responses of mesencephalic dopamine neurons to dorsal raphe stimulation in 5-HT-depleted rats. Society of Neuroscience Abstracts, 19, 1372.
23. Gold LH and Balster RL (1992) Effects of buspirone and gepirone on IV self-administration in rhesus monkeys. Psychopharmacology, 108, 289-294.
24. Heimer L, de Olmos J, Alheid GF and Záborszky L (1991) 'Perestroika' in the basal forebrain: opening the border between neurology and psychiatry. Progress in Brain Research, 87, 109-165.
25. 1A agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology, 338, 463-471.
26. Hollister AS, Breese GR, Moreton Kuhn C, Cooper BR and Schanberg SM (1976) An inhibitory role for brain serotonin-containing systems in the locomotor effects of D-amphetamine. Journal of Pharmacology and Experimental Therapeutics, 198, 12-22.
27. 1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens. European Journal of Pharmacology, 287, 179-184.
28. 1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology, 27, 515-518.
29. Jackson DM and Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacology and Therapeutics, 64, 291-369.
30. Jackson DM, Johansson C, Lindgren L-M and Bengtsson A (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacology, Biochemistry and Behavior, 48, 465-471.
31. Kelly PH and Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. European Journal of Pharmacology, 40, 45-56.
32. Leccese AP and Lyness WH (1984) The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions. Brain Research, 303, 153-162.
33. Loh EA and Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology, 101, 262-266.
34. Mabry PD and Campbell BA (1973) Serotoninergic inhibition of catecholamine-induced behavioral arousal. Brain Research, 49, 381-391.
35. 1 recognition sites. European Journal of Pharmacology, 90, 151-153.
36. Morrow BA and Roth RH (1996) Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse, 23, 174-181.
37. 3 receptor antagonists on the discriminative stimulus effects of amphetamine. European Journal of Pharmacology, 212, 271-274.
38. 1A agonists. Behavioural Pharmacology, 5, 591-598.
39. Neill DB, Grant LD and Grossman SP (1972) Selective potentiation of locomotor effects of amphetamine by midbrain raphe lesions. Physiology and Behavior, 9, 655-657.
40. Nielsen EB and Scheel-Kruger J (1986) Cuening effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. European Journal of Pharmacology, 125, 85-92.
41. Peltier R and Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology, 110, 390-394.
42. 1A receptor in the rat brain: correlation with receptor binding. Journal of Neuroscience, 12, 440-453.
43. Prisco S, Pagannone S and Esposito E (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. Journal of Pharmacology and Experimental Therapeutics, 271, 83-90.
44. Protais P, Costentin J and Schwartz JC (1976) Climbing behaviour induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology, 50, 1-6.
45. Protais P, Chagraoui A, Arbaoui J and Mocaër E (1994) Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents. European Journal of Pharmacology, 271, 167-177.
46. Przegaliñski E and Filip M (1997) Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminomimetics in rats. Polish Journal of Pharmacology, 49, 291-298.
47. Przegaliñski E, Filip M, Budziszewska B and Chojnacka-Wójcik E (1994) Antagonism of(+)WAY 100135 to behavioural, hypothermic and corticosterone effects induced by 8-OH-DPAT. Polish Journal of Pharmacology, 46, 21-27.
48. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. European Journal of Pharmacology, 186, 327-330.
49. Sokal RR and Rolhf FJ (1981) Randomized blocks for frequency data. In: Biometry (Ed. WH Freeman and Co.), pp. 767-774. New York.
50. Skuza G, Rogóz Z, Quack G and Danysz W (1994) Memantine, amantadine, and L-deprenyl potentiate the action of 1-DOPA in monoamine-depleted rats. Journal of Neural Transmission (Gen Sect), 98, 57-67.
51. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology, 112, 93-99.
52. 3 antagonist, reduces cocaine's psychomotor stimulated effects in the rat. Psychopharmacology (ABSTRACT), 101, S59.
53. Van Rossum JM (1967) The significance of dopamine receptor blockade for the action for neuroleptic drugs. In: Neuropsychopharmacology (Ed. H. Brill), pp. 321-329. Excerpta Medica Foundation, New York.
54. Van Wijngaarden I, Tulp MTM and Soudijn W (1990) The concept of selectivity in 5-HT receptor research. European Journal of Pharmacology-Molecular Pharmacology Section, 188, 301-312.
55. Warbritton III JD, Stewart RM and Baldessarini RJ (1978) Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Research, 143, 373-382.